Skip to main content
. 2020 Apr;8(7):489. doi: 10.21037/atm.2020.03.49

Table 2. Independent predictors of PMRT receipt.

Variables OR 95% CI P
Year of diagnosis
   2004 1
   2005 0.929 0.760–1.135 0.471
   2006 0.991 0.815–1.205 0.928
   2007 1.183 0.983–1.423 0.075
   2008 1.369 1.142–1.640 0.001
   2009 1.291 1.077–1.547 0.006
   2010 1.548 1.293–1.855 <0.001
   2011 1.986 1.653–2.386 <0.001
   2012 2.142 1.776–2.582 <0.001
Age (years)
   <50 1
   ≥50 0.623 0.573–0.678 <0.001
Race/ethnicity
   Non-Hispanic White 1
   Non-Hispanic Black 1.101 0.967–1.253 0.147
   Hispanic (all races) 0.853 0.748–0.972 0.017
   Other 0.978 0.852–1.124 0.759
Grade
   Well differentiated 1
   Moderately differentiated 1.409 1.182–1.679 <0.001
   Poorly/undifferentiated 1.745 1.468–2.073 <0.001
Tumor stage
   T1 1
   T2 1.583 1.449–1.729 <0.001
Number of positive lymph nodes (n)
   1 1
   2 1.497 1.360–1.648 <0.001
   3 2.640 2.367–2.948 <0.001
ER status
   Negative 1
   Positive 0.963 0.838–1.106 0.595
PR status
   Negative 1
   Positive 0.961 0.847–1.091 0.543
Marital status
   Unmarried 1
   Married 1.004 0.917–1.099 0.932

PMRT, postmastectomy radiotherapy; CI, confidence interval; ER, estrogen receptor; OR, odds ratio; PR, progesterone receptor.